Congenital Afibrinogenemia: First Identification of Splicing Mutations in the Fibrinogen Bbeta -Chain Gene Causing Activation of Cryptic Splice Sites

Blood - United States
doi 10.1182/blood-2002-06-1647
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Novel Fibrinogen Bbeta Chain Mutation as an Underlying Mechanism of Afibrinogenemia?

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2015English

Fibrinogen Martin: A Novel Mutation in FGB (Gln180Stop) Causing Congenital Afibrinogenemia

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2016English

Mechanism for Cryptic Splice Site Activation During Pre-mRNA Splicing.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

Congenital Afibrinogenemia

Annals of Saudi Medicine
Medicine
2000English

Myosin Light-Chain 1/3 Gene Alternative Splicing: Cis Regulation Is Based Upon a Hierarchical Compatibility Between Splice Sites.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1990English

New POMT2 Mutations Causing Congenital Muscular Dystrophy: Identification of a Founder Mutation

Neurology
Neurology
2007English

Disease-Causing Mutations in Proteins: Structural Analysis of the CYP1b1 Mutations Causing Primary Congenital Glaucoma in Humans

Biophysical Journal
Biophysics
2006English

Differential Regulation of Fibrinogen Γ Chain Splice Isoforms by Interleukin-6

Thrombosis Research
Hematology
2013English

Identification of a Bidirectional Splicing Enhancer: Differential Involvement of SR Proteins in 5′ or 3′ Splice Site Activation

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy